Most people assume Indian women go undiagnosed because they do not seek care. Time, cost, a family that comes first.
The evidence points somewhere else.
They reach care. Often more than once.
In a study of 275 women with PCOS, now renamed PMOS, at a national referral hospital in north India, almost all of them had already been somewhere else first (Kaur et al., 2021).
85.8%
had already consulted more than one health care agency.
Kaur et al., 2021. 275 women with PCOS at a national referral hospital in north India.
Half had seen two or three. Around one in six had seen more than four.
The study counts agencies, not doctors, and in India those are not the same thing. Care here is not one system. Alongside allopathic medicine sit the traditional systems the government groups under AYUSH, which stands for Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy, and a good deal of informal advice besides. She is not booking four appointments. She is trying four different kinds of help.
These were women who persisted all the way to a tertiary hospital. They are not the hardest to reach. They are among the most determined, which means the picture outside this group is unlikely to be better.
Nor is it the money, though money is a burden. Rajasthan made public hospital care free for 46 million people. Women used more hospital care than they had before, and still less of it than men. Making it free did not close that gap (Dupas and Jain, 2024). That finding covers inpatient care among people below the poverty line in one state, and more than 60% of the women in the north Indian study described their treatment as moderately to very expensive (Kaur et al., 2021). Cost makes all of this harder. It is not what decides who gets seen.
What she gets when she gets there
Where Indian women with PMOS got information about their condition:
9.1%
from a doctor
37.5%
from the internet
44.7%
had no information at all
A consultation runs to minutes and a hormonal condition runs to years, so the explaining has never fitted inside the appointment. It happens somewhere else or it does not happen. In India, somewhere else is currently a supplement company.
This is where the access explanation runs out entirely. She got there. She was seen. She left without the thing she came for, and only one in three found their first treatment effective. The rest kept looking, which is how a woman ends up at her fourth agency.
If you have one coming up, our appointment prep pages cover what to take and what to ask before you leave. If you are not sure who to see in the first place, we have written about which doctor handles what.
Which symptoms get chased
A 2026 review pooled Indian studies on health-seeking across different kinds of reproductive morbidity, and found an ordering.
Reproductive conditions, ordered by how readily care is sought:
Chased most
- Infertility
- Pregnancy and post-pregnancy conditions
- Reproductive tract infections
- Menopause-related and gynaecological conditions
- Menstrual problems
Chased least
Care-seeking was highest by a wide margin for infertility. It fell through pregnancy and post-pregnancy conditions, then reproductive tract infections, then menopause-related and gynaecological conditions. It was lowest of all for menstrual problems. Roughly sixty percentage points separate the top of that list from the bottom (Karthikeyan et al., 2026).
Attention follows reproductive outcome. A condition that threatens fertility or a pregnancy gets chased. A condition that changes a woman's periods gets chased least.
Which is the whole problem, because a changed period is how most hormonal conditions announce themselves. She is not being ignored for want of trying. She is presenting with the symptom the system is least organised to chase, and every extra agency she visits is her doing the chasing herself.
One thing to know about that review before carrying the finding anywhere. Its pooled percentages are not usable and we have not quoted any of them, because the studies inside it disagree with each other so completely that an averaged figure would describe the averaging rather than India. What survives is the order, since a sixty-point spread inside one population is not something averaging can invent. We are using a weaker source for the single thing in it that holds. The review also leaves out PMOS and thyroid disease, so this describes the pattern rather than either condition.
What these numbers can and cannot tell you
All of this is narrower than a national picture. The north Indian study is one hospital and one condition, and everyone in it had persisted all the way to tertiary care rather than dropping out along the way. The 2026 review covers reproductive morbidity and leaves out both PMOS and thyroid disease. The Rajasthan finding covers inpatient care among people below the poverty line in a single state.
Sources
- Kaur I, Suri V, Rana SV, Singh A. "Treatment pathways traversed by polycystic ovary syndrome (PCOS) patients: A mixed-method study." PLOS ONE. 2021;16(8):e0255830. doi:10.1371/journal.pone.0255830
- Dupas P, Jain R. "Women Left Behind: Gender Disparities in Utilization of Government Health Insurance in India." American Economic Review. 2024;114(10):3345–3385. doi:10.1257/aer.20230521
- Karthikeyan S, Alwar S, Janardhanan R, Haridoss M. "Reproductive health seeking behaviour and its determinants in Indian women: a systematic review and meta-analysis." Frontiers in Reproductive Health. 2026;8:1769536. doi:10.3389/frph.2026.1769536
Anayah is being built for women navigating PMOS, thyroid conditions and everything that comes after. If you would like to know when it is ready, join the waitlist. We will email you once, when there is something worth your time.
Anayah does not provide medical advice, diagnosis or treatment. Nothing here replaces a consultation with a qualified doctor.